Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents
Inorganic Chemistry · 06.05.2024 · 63 (18) · 8462-8475
DOI: 10.1021/acs.inorgchem.4c01028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 20.04.2024. Verfasst von Yong Jian und 15 weiteren Autor:innen. Beteiligte Einrichtung: Joint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China 325035. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging, Chelating Agents, Gadolinium. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau, Anhui Laboratory of Molecule-Based Materials, Anhui Normal University, Wenzhou Institute of Biomaterials and Engineering.
Abstract (Originalsprache)
In recent years, pyclen-based complexes have attracted a great deal of interest as magnetic resonance imaging (MRI) contrast agents (CAs) and luminescent materials, as well as radiopharmaceuticals. Remarkably, gadopiclenol, a Gd(III) bishydrated complex featuring a pyclen-based heptadentate ligand, received approval as a novel contrast agent for clinical MRI application in 2022. To maximize stability and efficiency, two novel chiral pyclen-based chelators and their complexes were developed in this study. Gd-X-PCTA-2 showed significant enhancements in both thermodynamic and kinetic stabilities compared to those of the achiral parent derivative Gd-PCTA. 1H NMRD profiles reveal that both chiral gadolinium complexes (Gd-X-PCTA-1 and Gd-X-PCTA-2) have a higher relaxivity than Gd-PCTA, while variable-temperature 17O NMR studies show that the two inner-sphere water molecules have distinct residence times τMa and τMb. Furthermore, in vivo imaging demonstrates that Gd-X-PCTA-2 enhances the signal in the heart and kidneys of the mice, and the chiral Gd complexes exhibit the ability to distinguish between tumors and normal tissues in a 4T1 mouse model more efficiently than that of the clinical agent gadobutrol. Biodistribution studies show that Gd-PCTA and Gd-X-PCTA-2 are primarily cleared by a renal pathway, with 24 h residues of Gd-X-PCTA-2 in the liver and kidney being lower than those of Gd-PCTA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Joint Centre of Translational Medicine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China 325035.
- Joint Centre of Translational Medicine, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, People's Republic of China 325000.
- Sichuan Key Laboratory of Medical Imaging, School of Pharmacy and Nanchong Key laboratory of MRI Contrast Agent, North Sichuan Medical College, Nanchong, People's Republic of China 637000.
- Department of Radiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, People's Republic of China 325027.
- Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale T. Michel 11, Alessandria, Italy 15121.
- Departamento de Química Fundamental, Facultade de Ciencias, Universidade da Coruña, Campus da Zapateira-Rúa da Fraga 10, A Coruña, Spain 15008.
ORCID-Profile: Jiang Zhu, Fabio Carniato, Carlos Platas-Iglesias, Fangfu Ye, Mauro Botta, Lixiong Dai
Förderung
- Wenzhou Municipal Science and Technology Bureau
- Anhui Laboratory of Molecule-Based Materials, Anhui Normal University
- Wenzhou Institute of Biomaterials and Engineering
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Jian, Y., Mo, G., Xu, W., Liu, Y., Zhang, Z., Ding, Y., Gao, R., Xu, J., Zhu, J., Shu, K., Yan, Z., Carniato, F., Platas-Iglesias, C., Ye, F., Botta, M., & Dai, L. (2024). Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents. Inorganic Chemistry, 63(18), 8462-8475. https://doi.org/10.1021/acs.inorgchem.4c01028
Vancouver
Jian Y, Mo G, Xu W, Liu Y, Zhang Z, Ding Y, et al. Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents. Inorganic Chemistry. 2024;63(18):8462-8475. doi:10.1021/acs.inorgchem.4c01028
BibTeX
@article{Jian2024,
author = {Jian, Yong and Mo, Gengshen and Xu, Weiyuan and Liu, Yao and Zhang, Zhichao and Ding, Yinghui and Gao, Ruonan and Xu, Jiao and Zhu, Jiang and Shu, Kun and Yan, Zhihan and Carniato, Fabio and Platas-Iglesias, Carlos and Ye, Fangfu and Botta, Mauro and Dai, Lixiong},
title = {Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents},
journal = {Inorganic Chemistry},
year = {2024},
volume = {63},
number = {18},
pages = {8462--8475},
doi = {10.1021/acs.inorgchem.4c01028}
}
EUVIMED